封面
市场调查报告书
商品编码
1535725

肝臟保健补充剂市场 - 副产品(维生素、矿物质、草药补充剂)、用途(人类、兽医)、剂型(胶囊、片剂、液体)、配销通路(大型超市、电子商务、零售药局)、2024 年全球预测 - 2032

Liver Health Supplements Market - By Product (Vitamins, Minerals, Herbal Supplements), Use (Human, Veterinary), Dosage Form (Capsule, Tablets, Liquid), Distribution Channel (Hypermarkets, E-commerce, Retail Pharmacies), Global Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 252 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于补充剂配方的进步和消费者对天然产品的偏好日益增长,全球肝臟健康补充剂市场在 2024 年至 2032 年间将呈现 5.6% 的复合年增长率。将有效草药成分与现代输送系统相结合的创新增强了这些补充剂的功效和吸引力。消费者越来越多地寻求天然的、基于植物的肝臟健康解决方案,反映出向整体和预防方法的转变。这种结合先进配方和天然成分的趋势符合对安全、有效和永续肝臟健康解决方案的需求,推动了产业成长。

例如,2023 年3 月,Gencor 推出了4Liver,这是一种阿育吠陀肝保健补充剂,结合了榄仁果和白头骨花提取物,这两种提取物传统上用于阿育吠陀医学中的肝臟支撑。这一发展表明消费者对整体和草药肝臟健康方法的兴趣日益浓厚,从而扩大了市场,以包括更加多样化和具有文化根源的产品。它也反映出人们对阿育吠陀解决方案的更广泛接受,以及将经过时间考验的草药成分融入现代保健品中。

肝臟保健品产业根据产品、用途、剂型、配销通路和地区进行细分。

由于其便利性、精确剂量和广泛的消费者偏好,到 2032 年,片剂市场将占据显着的市场份额。片剂为个人提供了一种实用且一致的方式,将肝臟保健补充剂纳入日常生活中。它们易于储存、运输和管理,使其成为消费者的热门选择。此外,片剂形式包含多种活性成分的能力增强了它们的吸引力,有助于它们在行业中的主导地位。

由于维生素在支持肝功能和整体健康方面发挥重要作用,到 2032 年,维生素领域将获得相当大的立足点。复合维生素 B、维生素 C 和维生素 E 等维生素因其解毒和抗氧化支持等肝臟保护特性而备受推崇。消费者越来越多地寻求这些有益的营养素来维持肝臟健康并预防肝臟相关问题。维生素的健康益处及其融入日常健康习惯的广泛认可有助于其在肝臟保健补充剂市场中的领先地位。

到 2032 年,亚太地区肝臟保健补充剂行业份额将以显着的复合年增长率扩大,这归因于该地区健康意识的提高、城市化程度的提高以及可支配收入的增长。随着与生活方式相关的肝臟问题变得越来越普遍,消费者正在寻求补充剂来支持肝功能和整体健康。此外,许多亚洲文化中的传统做法和自然疗法也增加了对肝臟保健补充剂的需求。该地区不断发展的工业,受到当代和传统健康实践的影响,使其成为全球市场扩张的主要贡献者。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 肝病盛行率增加
      • 草药和天然补充剂的上升趋势
      • 健康意识不断提高
    • 产业陷阱与挑战
      • 缺乏标准化和品质控制
  • 成长潜力分析
  • 监管环境
  • 定价分析
  • 未来市场趋势
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 战略仪錶板

第 5 章:市场估计与预测:按产品分类,2021 - 2032 年

  • 主要趋势
  • 维生素
  • 矿物质
  • 草药补充剂
  • 其他产品

第 6 章:市场估计与预测:按用途分类,2021 - 2032 年

  • 主要趋势
  • 人类
  • 兽医

第 7 章:市场估计与预测:按剂型,2021 - 2032

  • 主要趋势
  • 胶囊
  • 平板电脑
  • 液体
  • 其他剂型

第 8 章:市场估计与预测:按配销通路划分,2021 - 2032 年

  • 主要趋势
  • 大型超市
  • 电子商务
  • 药局和零售药局
  • 其他分销管道

第 9 章:市场估计与预测:按地区,2021 - 2032

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章:公司简介

  • AdvaCare Pharma
  • Carbamide Forte
  • Dabur
  • Gaia Herbs
  • Himalaya Wellness Company
  • iHerb, LLC
  • Integria Healthcare Pvt. Ltd.
  • Inlife Pharma Pvt. Ltd
  • Irwin Naturals
  • Jarrow, Formula, Inc.
  • Life Extension
  • Metagenics Pvt. Ltd.
  • Nature's Way
  • Nestle S.A.
  • NOW Foods
  • Nutralife Health Product, Inc.
  • Solaray
  • Swisse
简介目录
Product Code: 9890

Global Liver Health Supplements Market will exhibit a 5.6% CAGR between 2024 and 2032 due to advancements in supplement formulations and growing consumer preference for natural products. Innovations in combining effective herbal ingredients with modern delivery systems enhance the efficacy and appeal of these supplements. Consumers increasingly seek natural, plant-based solutions for liver health, reflecting a shift towards holistic and preventive approaches. This trend towards incorporating advanced formulations and natural ingredients aligns with the demand for safe, effective, and sustainable liver health solutions, thus fueling industry growth.

For instance, in March 2023, Gencor introduced 4Liver, an Ayurvedic liver health supplement combining Terminalia chebula fruit and Sphaeranthus indicus flower extracts, both traditionally used for liver support in Ayurvedic medicine. This development indicates a rising consumer interest in holistic and herbal approaches to liver health, expanding the market to include more diverse and culturally rooted products. It also reflects a broader acceptance of Ayurvedic solutions and the integration of time-tested herbal ingredients into modern health supplements.

The liver health supplements industry is segmented based on product, use, dosage form, distribution channel, and region.

The tablets segment will witness a remarkable market share by 2032, fueled by their convenience, precise dosage, and widespread consumer preference. Tablets offer a practical and consistent way for individuals to incorporate liver health supplements into their daily routines. They are easy to store, transport, and administer, making them a popular choice among consumers. Besides, the ability to include a wide range of active ingredients in tablet form enhances their appeal, contributing to their dominance in the industry.

The vitamins segment will gain a considerable foothold by 2032, owing to their essential role in supporting liver function and overall health. Vitamins such as B-complex, C, and E are well-regarded for their liver-protective properties, including detoxification and antioxidant support. Consumers increasingly seek these beneficial nutrients to maintain liver health and prevent liver-related issues. The widespread recognition of vitamins' health benefits and their integration into daily health routines contribute to their leading position in the liver health supplements market.

Asia Pacific liver health supplements industry share will expand at a noteworthy CAGR through 2032, attributed to rising health awareness, increasing urbanization, and growing disposable incomes across the region. As lifestyle-related liver issues become more prevalent, consumers are seeking supplements to support liver function and overall health. Additionally, traditional practices and natural remedies in many Asian cultures contribute to the demand for liver health supplements. The region's growing industry, influenced by both contemporary and traditional health practices, establishes it as a primary contributor to global market expansion.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360º synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of liver disease
      • 3.2.1.2 Rising trend of herbal and natural supplements
      • 3.2.1.3 Rising health awareness
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Lack of standardization and quality control
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Pricing analysis
  • 3.6 Future market trends
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Vitamins
  • 5.3 Minerals
  • 5.4 Herbal supplements
  • 5.5 Other products

Chapter 6 Market Estimates and Forecast, By Use, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Human
  • 6.3 Veterinary

Chapter 7 Market Estimates and Forecast, By Dosage Form, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Capsules
  • 7.3 Tablets
  • 7.4 Liquids
  • 7.5 Other dosage forms

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hypermarkets
  • 8.3 E-commerce
  • 8.4 Drug store & retail pharmacies
  • 8.5 Other distribution channels

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 AdvaCare Pharma
  • 10.2 Carbamide Forte
  • 10.3 Dabur
  • 10.4 Gaia Herbs
  • 10.5 Himalaya Wellness Company
  • 10.6 iHerb, LLC
  • 10.7 Integria Healthcare Pvt. Ltd.
  • 10.8 Inlife Pharma Pvt. Ltd
  • 10.9 Irwin Naturals
  • 10.10 Jarrow, Formula, Inc.
  • 10.11 Life Extension
  • 10.12 Metagenics Pvt. Ltd.
  • 10.13 Nature's Way
  • 10.14 Nestle S.A.
  • 10.15 NOW Foods
  • 10.16 Nutralife Health Product, Inc.
  • 10.17 Solaray
  • 10.18 Swisse